Mikhail Romashko
Tufts Medical Center
7 Papers
18 Citations
Mikhail Romashko is an academic researcher from Tufts Medical Center. The author has contributed to research in topics: Hypertrophic cardiomyopathy & Muscle hypertrophy. The author has an hindex of 2, co-authored 6 publications.
Chat about Author
Papers
Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic Cardiomyopathy.
Martin S. Maron,Ethan J. Rowin,Benjamin S. Wessler,Paula Mooney,Amber Fatima,Parth P. Patel,Benjamin Koethe,Mikhail Romashko,Mark S. Link,Mark S. Link,Barry J. Maron +10 more
TL;DR: A systematic enhanced ACC/AHA guideline and practice-based risk factor strategy prospectively predicted SCD events in nearly all at-risk patients with HCM, resulting in prophylactically implanted ICDs that prevented many catastrophic arrhythmic events in this at- risk population.
Impact of Effective Management Strategies on Patients With the Most Extreme Phenotypic Expression of Hypertrophic Cardiomyopathy
Ethan J. Rowin,Barry J. Maron,Mikhail Romashko,Wendy Wang,Hassan Rastegar,Mark S. Link,Martin S. Maron +6 more
TL;DR: In this referral-based population, patients with the most extreme expression of HC are at increased arrhythmic sudden death risk reliably prevented with prophylactic ICDs, and with contemporary treatment interventions young HC patients have an opportunity to achieve extended survival with good quality of life.
19
Hypertrophic cardiomyopathy - phenotypic variations beyond wall thickness.
Nikhil Goyal,G. Keir,Yonah B. Esterson,Shahryar G Saba,Stuart L. Cohen,Ethan J. Rowin,Mikhail Romashko,Jesse Chusid +7 more
TL;DR: In this paper , the appearance of morphologic variations seen in HCM beyond myocardial thickening including: papillary muscle and mitral valve variants, myocardia crypts, left ventricular myocardian bands, and dystrophic calcification related to increased wall tension.
1
Management Implications of Hypertrophic Cardiomyopathy Patients with Massive Hypertrophy
Mikhail Romashko,Ethan J. Rowin +1 more
- 01 Jan 2020
TL;DR: In this article, the authors discuss management considerations for HCM patients with massive LV hypertrophy including consideration for primary prevention implantable cardioverter defibrillator placement, and increased risk of progressive heart failure symptoms secondary to obstruction, relieved with myectomy.